-+ 0.00%
-+ 0.00%
-+ 0.00%

Telo Genomics Announces Secured Convertible Debenture Offering of Up to $1 Million

PUBT·11/20/2026 11:32:31
Listen to the news
Telo Genomics Announces Secured Convertible Debenture Offering of Up to $1 Million
  • Telo Genomics announced a non-brokered private placement of up to $1 million in secured convertible debentures.
  • The debentures bear 15% annual interest, compounded quarterly, with maturity 12 months from issuance.
  • Holders may convert principal into common shares at $0.05 per share before maturity; early repayment is prohibited.
  • Investors receive 2 million detachable warrants per $100,000 issued, exercisable at $0.08 per share for 12 months from issuance.
  • Proceeds will fund lab trials and general working capital.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Telo Genomics Corp. published the original content used to generate this news brief via Newsfile (Ref. ID: 202611200630NEWSFILECNPR____20261120_324996_1) on November 20, 2026, and is solely responsible for the information contained therein.